Expertise in
12
conditions

Carlo Vancheri

Ct, 
Catania, IT 
Expertise in
12
conditions
Ct, 
Catania, IT 

Overview

Carlo Vancheri practices practicing medicine in Catania, Italy.

Mr. Vancheri is highly rated in 12 conditions, according to our data. His clinical expertise encompasses Idiopathic Pulmonary Fibrosis, Pulmonary Fibrosis, Interstitial Lung Disease, Lung Transplant, and Endoscopy.

He is actively involved in clinical research, co-authoring 207 peer reviewed articles and participating in 2 clinical trials.

Gender

Male

Locations

Ct, Catania, Italy

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: September 19, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Zephyrus II: A Phase 3, Randomized, Double-Blind, Placebo-Controlled Efficacy and Safety Study of Pamrevlumab in Subjects With Idiopathic Pulmonary Fibrosis (IPF)
Enrollment Status: Terminated
Publish Date: August 12, 2024
Intervention Type: Drug
Study Drug: Pamrevlumab
Study Phase: Phase 3
View 1 Less Clinical Trial

207 Total Publications

miR-205-5p promotes endothelial dysfunction and senescence in pulmonary fibrosis.
miR-205-5p promotes endothelial dysfunction and senescence in pulmonary fibrosis.
Journal: JCI insight
Published: May 28, 2026

Frequently Asked Questions about Carlo Vancheri

Is Carlo Vancheri a top-rated expert for Idiopathic Pulmonary Fibrosis?

MediFind is an objective health platform that identifies experts based on real-world data. Carlo Vancheri is classified as an Elite expert for Idiopathic Pulmonary Fibrosis, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Carlo Vancheri participate in research or clinical trials?

Yes. Carlo Vancheri has published 207 articles and abstracts on conditions like Idiopathic Pulmonary Fibrosis. You can view a list of Carlo Vancheri's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Vancheri's expertise for a condition
ConditionClose
View All 43 Experienced Conditions
Want to save this expert for later?
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile